This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Csl Behring Gmbh. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ernst-Juergen Kanzy: Innovator in Pharmaceutical Formulations
Introduction
Ernst-Juergen Kanzy is a notable inventor based in Weimar, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that enhance the stability of therapeutic agents.
Latest Patents
Kanzy holds a patent for "Pharmaceutical formulations of C1 esterase inhibitor." This invention relates to pharmaceutical formulations comprising the C1 esterase inhibitor (C1-INH), which exhibits higher stability for prolonged storage. It also reduces the formation of aggregates of the esterase inhibitor during storage, thereby improving its efficacy in treating or preventing disorders related to kinin formation. He has 1 patent to his name.
Career Highlights
Kanzy is associated with Csl Behring GmbH, a company known for its focus on biopharmaceuticals. His work has contributed to advancements in the treatment of various medical conditions, showcasing his expertise in pharmaceutical sciences.
Collaborations
One of his notable collaborators is Hubert Metzner, with whom he has worked on various projects within the pharmaceutical domain.
Conclusion
Ernst-Juergen Kanzy's innovative work in pharmaceutical formulations highlights his commitment to improving medical treatments. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile